C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 221/18 (2006.01) A61K 31/47 (2006.01) A61K 31/695 (2006.01) C07D 401/12 (2006.01) C07D 405/12 (2006.01) C07D 491/056 (2006.01) C07F 7/10 (2006.01)
Patent
CA 2227585
The present invention is directed to novel dopamine receptor ligands of formula (I), pharmaceutical formulations of such compounds, and a method using such compounds for treating a patient suffering from dopamine-related dysfunction of the central or peripheral nervous system.
L'invention se rapporte à des nouveaux ligands pour récepteurs de la dopamine, représentés par la formule (I), les formulations pharmaceutiques de ces composés, et un procédé dans lequel ces composés sont utilisés pour traiter un patient souffrant d'un dysfonctionnement du système nerveux périphérique ou central, lié à la dopamine.
Ghosh Debasis
Mailman Richard
Nichols David E.
Purdue Research Foundation
Smart & Biggar
University Of North Carolina At Chapel Hill
LandOfFree
Novel fused isoquinolines as dopamine receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel fused isoquinolines as dopamine receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel fused isoquinolines as dopamine receptor ligands will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1499952